CÀRNIQUES CELRÀ ENTERS THE PHARMACEUTICAL INDUSTRY
Càrniques Celrà has launched the Glicopepton Biotech project, which will allow the transformation of pig mucosa into a high value-added biotechnological product, such as heparin.
Càrniques Celrà has launched the Glicopepton Biotech project, which will allow the transformation of pig mucosa into a high value-added biotechnological product, such as heparin.
